Log in to save to my catalogue
Log in to save to my catalogue

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College; Genetic...

| Ask | Become a Library member

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College; Genetic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_236875288

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College; Genetic testing may be valuable in treating colorectal cancer

About this item

Full title

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College; Genetic testing may be valuable in treating colorectal cancer

Publisher

Atlanta: NewsRx

Journal title

Clinical Oncology Week, 2009, p.634

Language

English

Formats

Newsletter articles

Publication information

Publisher

Atlanta: NewsRx

More information

Scope and Contents

Contents

2009 AUG 24 - ( NewsRx.com) -- For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe...

Alternative Titles

Full title

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College; Genetic testing may be valuable in treating colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_236875288

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_236875288

Other Identifiers

ISSN

1543-6799

E-ISSN

1543-6780

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections